InvestorsHub Logo
Followers 15
Posts 1613
Boards Moderated 0
Alias Born 12/13/2009

Re: falconer66a post# 439776

Wednesday, 11/22/2023 11:12:29 AM

Wednesday, November 22, 2023 11:12:29 AM

Post# of 465818

Could it be that Anavex is now pressing for blarcamesine as a treatment solely for the agitation and insomnia of Alzheimer’s, instead of a treatment for the cognition pathologies of that disease?



No--AVXL can't "press" for Blarcamesine as a treatment for insomnia, etc. without conducting clinical trials for those indications.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News